Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides

Farmaco

Volumn 54, Issue 1-2, 1999, Pages 83-89

  Wallis, Mark P ^a   Mahmood, Naheed ^b   Fraser, William ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b Rayne Inst 123 Cold Harbour L ^*  (United Kingdom)

Author keywords

Anti HIV; ATAZT; Nucleoside; Pyrimidine; Reverse transcriptase; Triazole

Indexed keywords

1 (BETA D ERYTHRO PENTOFURANOSYL) 4 PENTAFLUOROPHENYLOXY 2 (1H) PYRIMIDINONE; PYRIMIDINE NUCLEOSIDE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN;

ANTI-HIV AGENTS; CELL LINE; CELL SURVIVAL; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PLAQUE ASSAY; PYRIMIDINE NUCLEOSIDES; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

EID: 0032917922     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00107-4     Document Type: Article

References (20)

1. Erice A., Balfour H.H. Jr. Resistance of human immunodeficiency virus type-1 to antiretroviral agents - a review. Clin. Infect. Dis. 18:1994;149-156.
2. Mayers D. Rational approaches to resistance. AIDS (Suppl.). 10:1996;S9-S13.
3. Artico M. Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): a chemical survey from lead compounds to selected drugs for clinical trials. Farmaco. 51:1996;305-331.
4. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., Steitz T.A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 256:1992;1783-1790.
5. Wlodawer A., Miller M., Jaskolski M., Sathyanarayana B.K., Baldwin E., Weber I.T., Selk L.M., Clawson L., Schnieder L., Kent S.B.H. Conserved folding in retroviral proteases - crystal structure of a synthetic HIV-1 protease. Science. 245:1989;616-621.
6. Kempf D.J., Sham H.L., Marsh K.C., Flentge C.A., Betebenner D., Green B.E., McDonald E., Vasavanonda S., Saldivarm A., Wideburg N.E., Kati W.M., Ruiz L., Zhao C., Fino L.-M., Patterson J., Molla A., Plattner J.J., Norbeck D.W. Discovery of Ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J. Med. Chem. 41:1998;602-617.
7. Kim C.U., McGee L.R., Krawczyk S.H., Harwood E., Haranda Y., Swaminathan S., Bischofberger N., Chen M.S., Cherrington J.M., Xiong S.F., Griffin L., Cundy K.C., Lee A., Yu B., Gulnik S., Erickson J.W. New series of potent, orally bioavailable, non-peptidic cylcic sulphones as HIV-1 protease inhibitors. J. Med. Chem. 39:1996;3431-3434.
8. Hammer S.M., Squires K.E., Hughes M.D., Grimes J.M., Demeter L.M., Currier J.S., Eron J.J., Feinberg J.E., Balfour H.H., Dayton L.R., Chodakewitz J.A., Fischl M. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. New Engl. J. Med. 337:1997;725-733.
9. Fraser W., Schwalbe C.H. Evidence for an unusual conformation of AZT: crystal structure of a protected analogue. J. Pharm. Pharmacol. (Suppl. 2). 46:1994;1080.
10. Lin T.-S., Gao Y.-S., Mancini W.R. Synthesis and biological-activity of various 3′-azido and 3′-amino analogues of 5-substituted pyrimidine deoxyribonucleosides. J. Med. Chem. 26:1983;1691-1696.
11. Huang C.Y., Bi G., Miller P.S. Triplex formation by oligonucleotides containing novel deoxycytidine derivatives. Nucleic Acids Res. 24:1996;2606-2613.
12. Fathi R., Goswami B., Kung P.-P., Gaffney B.L., Jones R.A. Synthesis of 6-substituted 2′-deoxyguanosine derivatives using acetic anhydride in pyridine. Tetrahedron Lett. 39:1990;319-322.
13. Gao H., Fathi R., Gaffney B.L., Goswami B., Kung P.-P., Rhee Y., Jin R., Jones R.A. 6-O-(Pentafluorophenyl)-2′-deoxyguanosine - a versatile synthon for nucleoside and oligonucleotide synthesis. J. Org. Chem. 57:1992;6954-6959.
14. Wallis M.P., Spiers I.D., Schwalbe C.H., Fraser W. Structure of 1-(2′-deoxy-β-D-erythro-pentofuranosyl)-4-pentafluorophenyl- pyrimidin-2H-one. Tetrahedron Lett. 36:1995;3759-3763.
15. Rathbone D.L., O′Carroll B., Wallis M.P., Farrow K.C., Mahmood N., Schwalbe C.H., Fraser W. Isomorphous nucleosides with differing anti-HIV activity. J. Pharm. Pharmacol. (Suppl.). 50:1998;130.
16. W.L. Sung, Chemical conversion of thymidine into 5-methyl-2′-deoxycytidine, J. Chem. Soc., Chem. Commun. (1981) 1089.
17. Mahmood N. Karn J. HIV - A Practical Approach. 2:1995;271-287 IRL Press, Oxford.
18. Still W.C., Kahn M., Mitra A. Rapid chromatographic technique for separations with moderate resolution. J. Org. Chem. 43:1978;2923-2925.
19. Wienslow O.S., Kiser R., Fine D.L., Bader J., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects - application to high-efflux screening of synthetic and natural-products for AIDS-antiviral activity. J. Natl. Cancer Inst. 81:1989;577-586.
20. Mahmood N., Hay A.J. An ELISA utilizing immobilized snowdrop lectin GNA for the detection of envelope glycoproteins of HIV and SIV. J. Immunol. Methods. 151:1992;9-13.